This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Patrick, R. L. Search for Related Content PubMed PubMed Citation Articles by Patrick, R. L. Social Bookmarking                         What's this?

Synaptic Clefts Are Made to Be Crossed: Neurotransmitter Signaling in the Central Nervous System

Department of Neuroscience, Division of Biology and Medicine, Brown University, Providence, Rhode Island 02912

The primary means of communication between neurons in the mammalian central nervous system (CNS) is via release of chemical transmitters. Although the first transmitters to be discovered were the biogenic amines, such as acetylcholine and norepinephrine, involved in transmission in the autonomic nervous system, the contribution of other types of transmitters, such as amino acids and peptides, to CNS transmission has been the subject of recent study. Part of this interest stems from the relatively large percentage of neuronal connections that make use of amino acid transmitters such as gamma-aminobutyric acid and glutamate and also from the tremendous diversity possible when peptides are used as transmitters. Several disorders of CNS transmission are related to the degeneration of neuronal pathways in the brain. Two of the most prevalent neurologic disorders that result from degeneration are Alzheimer's and Parkinson's diseases. Aspects of these disorders related to chemical neurotransmission are discussed, along with implications with regard to therapeutic strategies. Functions of and possible abnormalities in amino acid transmission that may be associated with CNS disorders are examined. Several peptides are postulated to play a role in neurotransmission and concepts regarding the significance of the coexistence and release of biogenic amines and peptides at the same neuronal terminals are presented.

Key Words: Neurodegeneration • dopamine • acetylcholine • peptides • substance P • opioids • cytokines

References

• Agid Y., Javoy-Agid F., Ruberg M. (1987). Biochemistry of neurotransmitters in Parkinson's disease. Mov Disord 2: 166-230.
• Aimone LD, Yaksh TL (1989). Opioid modulation of capsaicinevoked release of substance P from spinal cord in vivo. Peptides 10: 1127-1131.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Bartfai T., Iverfeldt K., Fisone G., Serfözö P. (1988). Regulation of the release of coexisting neurotransmitters. Annu Rev Pharmacol Toxicol 28: 285-310.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Baumgarten HG, Jenner S., Björklund A., Klemm HP, Schlossberger HG (1982). Serotonin neurotoxins. In: Biology of Serotonergic Transmission, Osborne NN (ed). Wiley, Chichester, UK, pp 249-277.
• Campbell IL, Stalder Ak, Chiang CS, Bellinger R., Heyser CJ, Steffensen S., Masliah E., Powell HC, Gold LH, Henriksen SJ, Siggins GR (1997). Transgenic models to assess the pathogenic actions of cytokines in the central nervous system. Mol Psychiatr 2: 125-129.[Medline] [Order article via Infotrieve]
• Coyle JT, Schwarcz R. (1976). Model for Huntington's chorea: Lesions of striatal neurons with kainic acid. Nature 263: 244-246.[CrossRef][Medline] [Order article via Infotrieve]
• Crawley JN (1985). Comparative distribution of cholecystokinin and other neuropeptides: Why is this peptide different from all other peptides? Ann NY Acad Sci 448: 1-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Dingledine R., McBain CJ, McNamara JO (1990). Excitatory amino acid receptors in epilepsy. Trends Pharmacol Sci 11: 334-338.[CrossRef][Medline] [Order article via Infotrieve]
• Ensoli F., Fiorelli V., DeCristofaro M., Santini MD, Novi A., Vannelli B., Thiele CJ, Luzi G., Aiuti F. (1999). Inflammatory cytokines and HIV-1-associated neurodegeneration: Oncostatin-M produced by mononuclear cells from HIV-1-infected individuals induces apoptosis of primary neurons. J Immunol 162: 6268-6277.[Abstract/Free Full Text]
• Feldman RS, Meyer JS, Quenzer LF (1997). Principles of Neuro-psychopharmacology. Sinauer, Sunderland, Massachusetts.
• Geula C., Mesulam MM (1994). Cholinergic systems and related neuropathological predilection patterns in Alzheimer disease. In: Alzheimer Disease, Terry RD, Katzman R, Lick KL (eds). Raven Press, New York, pp 263-291.
• Heikkila RE, Sonsalla PK, Duviosin RC (1989). Biochemical models of Parkinson's disease. In: Neuromethods, Drugs as Tools in Neuroscience Research, Vol 12, Boulton AB, Baker GB, Juorio AV (eds). Human Press, Clifton, New Jersey, pp 351-384.
• Helke CJ, Krause JE, Mantyh PW, Couture R., Bannon MJ (1990). Diversity in mammalian tachykinin peptidergic neurons: Multiple peptides, receptors, and regulatory mechanisms. FASEB J 4: 1606-1615.[Abstract]
• Hornykiewicz O., Pifl C. (1994). The validity of the MPTP primate model for the neurochemical pathology of idiopathic Parkinson's disease. In: Noradrenergic Mechanisms in Parkinson's Disease, Briley M, Marien M (eds). CRC Press, Boca Raton, Florida, pp 11-23.
• Licinio J. (1997). Central nervous system cytokines and their relevance for neurotoxicity and apoptosis. J Neural Transm Suppl 49: 169-175.[Medline] [Order article via Infotrieve]
• McCann U., Hatzidimitriou G., Ridenour A., Fischer C., Yuan J., Katz J., Ricaurte G. (1994). Dexfenfluramine and serotonin neurotoxicity: Further preclinical evidence that clinical caution is indicated. J Pharmacol Exp Ther 269: 792-798.[Abstract/Free Full Text]
• Molliver ME, Berger UV, Mamounas LA, Molliver DC, O'Hearn E., Wilson MA (1990). Neurotoxicity of MDMA and related compounds: Anatomic studies. Ann NY Acad Sci 600: 640-664.[CrossRef][Web of Science]
• Olanow CW, Kordower JH, Freeman TB (1996). Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci 19: 102-109.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Pickel VM, Teitelman G. (1987). Immunocytochemistry of single and multiple antigens with special reference to the enzymes of catecholamine neurons. In: Monoaminergic Neurons: Light Microscopy and Ultrastructure, Steinbusch HWM (ed). Wiley, New York, pp 79-109.
• Roques BP, Beaumont A., Dauge V., Fournie-Zaluski MC (1993). Peptidase inactivation of enkephalins: Design of inhibitors and biochemical, pharmacological, and clinical applications. In: Opioids I, Handbook of Experimental Pharmacology, Vol 104, Herz A (ed). Springer-Verlag, New York, pp 547-584.
• Steinberg GK, Saleh J., Kunis D. (1988). Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemia. Neurosci Lett 89: 193-197.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Watling KJ, Krause JE (1993). The rising sun shines on substance P and related peptides. Trends Pharmacol Sci 14: 81-84.[CrossRef][Medline] [Order article via Infotrieve]
• Woodruff GN, Hughes J. (1991). Cholecystokinin antagonists. Annu Rev Pharmacol Toxicol 31: 469-501.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 28, No. 1, 31-36 (2000)
DOI: 10.1177/019262330002800105


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Patrick, R. L. Search for Related Content PubMed PubMed Citation Articles by Patrick, R. L. Social Bookmarking                         What's this?